Lexeo Therapeutics
Tracked across 1 events · 6 articles · First seen Sep 22, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Lexeo Therapeutics, Inc. (LXEO) announced a series of strategic transactions to expand its presence in Friedreich ataxia (FA), including a definitive agreement to acquire privately held clinical-stage company Ajax Therapeutics, Inc. The acquisition adds multiple…
Impact: Lexeo is the acquirer and central actor, expanding its Friedreich ataxia portfolio through the Mantle acquisition and three research collaborations. The deals broaden its pipeline and technology platform while maintaining cash runway into 2028, supporting a modestly positive market reaction.
Sep 22, 2026 · 6 articles
55
Lexeo Therapeutics signed option agreement Ajax TherapeuticsLexeo Acquires Mantle...
55
Lexeo Therapeutics signed option agreement Apertura Gene TherapyLexeo Acquires Mantle...
ERGEN INTELLIGENCE
Track Lexeo Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard